G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $683 | -52.0% | 474,080 | -17.1% | 0.00% | -50.0% |
Q2 2023 | $1,424 | +20.0% | 571,791 | +29.1% | 0.00% | 0.0% |
Q1 2023 | $1,187 | -66.2% | 442,975 | -31.5% | 0.00% | -60.0% |
Q4 2022 | $3,514 | -99.7% | 647,100 | +531.9% | 0.01% | +150.0% |
Q3 2022 | $1,279,000 | -44.2% | 102,400 | -77.9% | 0.00% | -33.3% |
Q2 2022 | $2,292,000 | -10.2% | 464,000 | +337.3% | 0.00% | 0.0% |
Q1 2021 | $2,553,000 | +117.5% | 106,100 | +50.1% | 0.00% | +200.0% |
Q1 2019 | $1,174,000 | +97.0% | 70,700 | +520.2% | 0.00% | 0.0% |
Q3 2018 | $596,000 | -49.7% | 11,400 | -64.4% | 0.00% | 0.0% |
Q2 2018 | $1,186,000 | 0.0% | 32,000 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $1,186,000 | – | 32,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
Birchview Capital, LP | 40,000 | $217 | 0.15% |
XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |